CRS-positive participants experienced an 18.5-fold higher median increase in CXCL10 compared with CRS-negative participants; for IFN-γ and TNF-α, the increase was 20-fold and ~2-fold higher, respectively, in favor of CRS-positive participants. This evidence concerns the gene CXCL10 and congenital rubella syndrome.